Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
FRIEDLANDS 10.000-JAHRE-SCHOCK: Der Kupfer-Engpass hat begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
539 Leser
Artikel bewerten:
(2)

Medical Elastomer Market worth $14.27 billion by 2029 - Exclusive Report by MarketsandMarkets

DELRAY BEACH, Fla. , Dec. 10, 2024 /PRNewswire/ -- The report "Medical Elastomer Market by Type (Thermoset Elastomers; Thermoplastic Elastomers), Applications (Medical Tubing; Catheters; Syringes; Gloves; Medical & Infusion Bags and Implants), End-use Industry & Region - Global Forecast to 2029", is projected to reach USD 14.27 billion by 2029 at a CAGR of 8.3% from USD 9.57 billion in 2024.

MarketsandMarkets

Browse in-depth TOC on "Medical Elastomer Market"

210 - Tables
45 - Figures
250 - Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191173877

The medical elastomer market is driven by the growing demand of medical devices fueled by expansion of healthcare technologies. Medical devices such as surgical instruments and diagnostic tools need components which are durable, flexible and biocompatible. The medical elastomers offer these properties. Additionally, the increased elderly population across the globe is enhancing the demand for devices such as catheters, syringes, and prosthetics where medical elastomers are crucial in order to ensure patient comfort and improved performance. Furthermore, the advancement in wearable medical devices and remote monitoring systems is also driving the demand for medical elastomers as such materials offering durable and comfortable designs. The globally risen healthcare expenditure as well as the continuous innovation and R&D is further increasing the demand for medical elastomers.

"Thermoplastic Elastomers are the fastest growing type in the medical elastomer market during the forecast period, in terms of value."

Thermoplastic elastomers are the fastest growing type of the medical elastomer. These elastomers are combination of unique properties such as elasticity, durability, and processability. Unlike traditional elastomers these can be processed like plastics along with retention of rubberlike properties. This makes them compatible for various medical applications. Their versatility increases their utility in various applications in the healthcare sector. These elastomers can be used to manufacture catheters, medical tubing, syringes, and wearable devices. In addition to this, they provide superior biocompatibility and sterilizability complying with strict healthcare regulations. Moreover, the increasing requirement for lightweight, flexible, and low-cost materials and R&D and innovations in TPE formulations are added factors driving the demand for thermoplastic elastomers in the medical elastomer market.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=191173877

"Catheters accounts second largest market share of medical elastomer market by application during the forecast period, in terms of value."

The catheters sector account the second largest market share in medical elastomer market due to their vital critical role in medical procedures such as urology, cardiology, and drug delivery. Medical elastomers offer the flexibility, biocompatibility, and durability required by catheter to ensure efficient performance resulting into patient safety and comfort. The increasing prevalence of chronic diseases like cardiovascular disorders and diabetes are resulting into rising demand for catheters for minimally invasive procedures. Moreover, ongoing innovations such as antimicrobial elastomers are further enhancing utility of the catheters in healthcare industry. This segment remains one of the key growth drivers within the medical elastomer market, which is increasingly growing due to demands in healthcare.

"North America accounts the largest share in medical elastomer market in terms of value."

North America accounts the largest share in medical elastomer market due to its well-established healthcare sector. The enhanced healthcare infrastructure, advanced medical technology and increasing expenditure on healthcare are strengthening the healthcare industry. Numerous major medical device manufacturers and pharmaceutical companies are located in the region. This is resulting into growing demand for medical elastomers in several applications such as instruments, drug delivery systems, and implants. Furthermore, stringent regulatory standards such as FDA regulations ensure the use of high quality materials which fuels the demand for innovative medical elastomer products. Finally, the growing aging population and the rising prevalence of chronic diseases within the region is further driving the demand for medical elastomers in the region.

Request Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=191173877

Acquisitions and expansions are the major growth strategies adopted by the key players in the market. The key global players in the medical elastomer market include BASF (Germany), Dow (US), Celanese Corporation (US), Eastman Chemical Company (US), Syensqo (Belgium), Mitsubishi Chemical Group Corporation (Japan), Kuraray Co., Ltd. (Japan), ExxonMobil (US), Momentive Performance Materials (US), Envalior (Germany) and Zeon Corporation (Japan).

Get access to the latest updates on Medical Elastomers Companies and Medical Elastomers Market Size

Browse Adjacent Market: Resins and Polymers Market Research Reports & Consulting

Related Reports:

Thermoplastic Elastomers Market - Global Forecast to 2028

Elastomers Market - Global Forecast to 2021

About MarketsandMarkets

MarketsandMarkets has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/medical-elastomer-market-worth-14-27-billion-by-2029--exclusive-report-by-marketsandmarkets-302327261.html

© 2024 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.